Bob Storey is Managing Director of The MVR Company, which focuses on the assessment and creation of new ventures, with a particular emphasis on medical technologies. He is also the Managing Partner of The LaunchPort™ in Baltimore, Maryland, an innovative manufacturing accelerator for medical devices entering the regulatory approval process. He is Chairman and board member for a number of early stage companies in orthopedics and cardiology.
He is currently serving on the External Advisory Board for the Johns Hopkins Center for Biomedical Innovation and Design, the Strategic Advisory Board for Johns Hopkins Laboratory for Computational Sensing and Robotics, the JHU Applied Physics Lab Technology Commercialization Panel, the Investment Review Committees for the Thalheimer and Bisciotti Funds, and is the Johns Hopkins advocate for medical device and engineering investment submissions to the Maryland Innovation Initiative.
He is appointed by the Governor to the State of Maryland’s Life Sciences Advisory Board serving as the Chair of the Medical Device group and is currently co-leading an effort to establish collaboration between the FDA, Payors, Device companies and Providers to develop a high value medical device demonstration hub in Maryland. He is the Medical Device expert for the National Institute of Health’s I-Corps @ NIH™ program, and is a Nationally Certified Instructor for the National Science Foundation’s I-Corps™. In his role at the national level, he has been the principal instructor for life science lean innovation programs at Johns Hopkins University, MD Anderson/Texas Medical Center, and for the University of Miami Biomedical Engineering/Miller School of Medicine. He has led international cohorts in the Lean Start-up area in Asia/Pacific, Middle East, South America and Africa.
Bob graduated from the University of Arkansas with degrees in Chemical Engineering and Chemistry in 1980, and initially worked in research, business development, marketing and general management for the engineering plastics businesses of Exxon Corporation and Clariant Corporation. He is a member of the UofA Biomedical Engineering Advisory Board and the Arkansas Academy of Chemical Engineers.